These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 26826115

  • 1. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
    Civenni G, Longoni N, Costales P, Dallavalle C, García Inclán C, Albino D, Nuñez LE, Morís F, Carbone GM, Catapano CV.
    Mol Cancer Ther; 2016 May; 15(5):806-18. PubMed ID: 26826115
    [Abstract] [Full Text] [Related]

  • 2. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
    Zhang Y, Lapidus RG, Liu P, Choi EY, Adediran S, Hussain A, Wang X, Liu X, Dan HC.
    Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
    [Abstract] [Full Text] [Related]

  • 3. STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population.
    Canesin G, Maggio V, Palominos M, Stiehm A, Contreras HR, Castellón EA, Morote J, Paciucci R, Maitland NJ, Bjartell A, Hellsten R.
    Sci Rep; 2020 Aug 18; 10(1):13958. PubMed ID: 32811873
    [Abstract] [Full Text] [Related]

  • 4. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
    Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM, Sethi G.
    J Mol Med (Berl); 2011 Jul 18; 89(7):713-27. PubMed ID: 21465181
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, Hong Z.
    Oncotarget; 2014 Sep 30; 5(18):8416-28. PubMed ID: 25261365
    [Abstract] [Full Text] [Related]

  • 6. β-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-ĸB signal pathways.
    Bao X, Zhu J, Ren C, Zhao A, Zhang M, Zhu Z, Lu X, Zhang Y, Li X, Sima X, Li J, Zhang Q, Ma B.
    Chem Biol Interact; 2021 Jun 01; 342():109477. PubMed ID: 33878321
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N.
    BMC Cancer; 2014 May 06; 14():317. PubMed ID: 24886434
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM, Fan M, Yang CH, Du Z, Sims M, Davidoff AM, Pfeffer LM.
    J Biol Chem; 2013 Sep 06; 288(36):26167-26176. PubMed ID: 23902772
    [Abstract] [Full Text] [Related]

  • 9. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
    Albino D, Civenni G, Rossi S, Mitra A, Catapano CV, Carbone GM.
    Oncotarget; 2016 Nov 22; 7(47):76756-76768. PubMed ID: 27732936
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C, Wang L, Wang H, Yang L, Guo H, Wang X.
    J Cell Biochem; 2013 Sep 22; 114(9):2061-70. PubMed ID: 23553622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D, Fu L, Sun H, Guo L, DuBois RN.
    Gastroenterology; 2015 Dec 22; 149(7):1884-1895.e4. PubMed ID: 26261008
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.
    Gu L, Liao Z, Hoang DT, Dagvadorj A, Gupta S, Blackmon S, Ellsworth E, Talati P, Leiby B, Zinda M, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Huszar D, Nevalainen MT.
    Clin Cancer Res; 2013 Oct 15; 19(20):5658-74. PubMed ID: 23942095
    [Abstract] [Full Text] [Related]

  • 17. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
    Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, Lele SM, Alnouti Y, Hollingsworth MA, Natarajan A.
    Clin Cancer Res; 2013 Apr 15; 19(8):2025-35. PubMed ID: 23444213
    [Abstract] [Full Text] [Related]

  • 18. 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling.
    Saha A, Blando J, Silver E, Beltran L, Sessler J, DiGiovanni J.
    Cancer Prev Res (Phila); 2014 Jun 15; 7(6):627-38. PubMed ID: 24691500
    [Abstract] [Full Text] [Related]

  • 19. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
    Chung SS, Vadgama JV.
    Anticancer Res; 2015 Jan 15; 35(1):39-46. PubMed ID: 25550533
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.